Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tove Dahl Scherdin"'
Autor:
Peter Hammarsten, Tove Dahl Scherdin, Christina Hägglöf, Pernilla Andersson, Pernilla Wikström, Pär Stattin, Lars Egevad, Torvald Granfors, Anders Bergh
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164016 (2016)
In the present study we have investigated whether Caveolin-1 expression in non-malignant and malignant prostate tissue is a potential prognostic marker for outcome in prostate cancer patients managed by watchful waiting. Caveolin-1 was measured in pr
Externí odkaz:
https://doaj.org/article/19fc74e6826340bcac466bc8024e3e45
Autor:
Paer Stattin, Anders Bergh, Hanibal Hani Adamo, Lars Egevad, Sofia Halin Bergström, Tove Dahl Scherdin, Peter Hammarsten, Christina Hägglöf
Publikováno v:
The Prostate. 79:435-445
Implantation of rat prostate cancer cells into the normal rat prostate results in tumor-stimulating adaptations in the tumor-bearing organ. Similar changes are seen in prostate cancer patients and they are related to outcome. One gene previously foun
Autor:
Pär Stattin, Pernilla Andersson, Pernilla Wikström, Anders Bergh, Lars Egevad, Peter Hammarsten, Torvald Granfors, Tove Dahl Scherdin, Christina Hägglöf
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164016 (2016)
PLoS ONE
PLoS ONE
In the present study we have investigated whether Caveolin-1 expression in non-malignant and malignant prostate tissue is a potential prognostic marker for outcome in prostate cancer patients managed by watchful waiting. Caveolin-1 was measured in pr
Publikováno v:
Cancer Research. 72:B68-B68
Although androgen deprivation is the standard therapy for metastatic prostate cancer the mechanisms for the initial response and subsequent relapse are largely unknown. The stroma and vasculature are necessary for castration-induced involution of the